Inventor · disambiguated record
David Szymkowski
Also filed as: SZYMKOWSKI DAVID · SZYMKOWSKI DAVID E · SZYMKOWSKI DAVID EDMUND
7 granted patents·10 pending applications·88 citations·filing 1995–2024
84Inventor score
Top patents by PatentIndex Score
17 records- 0194US7662367B2Pharmaceutical compositions for the treatment of TNF-α related disordersXENCOR INC·Filed 2006·Granted Feb 16, 2010·30 cites·6 claims
- 0294US7446174B2Protein based TNF-α variants for the treatment of TNF-α related disordersXENCOR INC·Filed 2005·Granted Nov 4, 2008·27 cites·20 claims
- 0375US7687461B2Treatment of TNF-α related disorders with TNF-α variant proteinsXENCOR INC·Filed 2004·Granted Mar 30, 2010·5 cites·11 claims
- 0469US2025129157A1Methods and compositions for treating multiple sclerosisZENAS BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0562US2006257360A1Protein based TNF-alpha variants for the treatment of TNF-alpha related disordersXENCOR INC·Filed 2006·Application pending·0 cites
- 0660US7141365B2Methods for diagnosing a mucin production associated disease conditionSYNTEX LLC·Filed 2001·Granted Nov 28, 2006·1 cites·2 claims
- 0760US6458940B2HPV-specific oligonucleotidesHYBRIDON INC·Filed 1997·Granted Oct 1, 2002·16 cites·30 claims
- 0855US2007172449A1TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERSXENCOR INC·Filed 2006·Application pending·0 cites
- 0948US2005096258A1Methods and compositions for treating gastrointestinal tract mucin production associated disease conditionsFiled 2004·Application pending·0 cites
- 1043US6509149B2HPV-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Jan 21, 2003·9 cites·43 claims
- 1143US2003064946A1Method and reagent for the inhibition of calcium activated chloride channel-1 (CLCA-1)Filed 2001·Application pending·0 cites
- 1242US2003059434A1Methods and compositions for treating gastrointestinal tract mucin production associated disease conditionsFiled 2001·Application pending·0 cites
- 1342US2003055240A1HPV specific oligonucleotidesFiled 2002·Application pending·0 cites
- 1441US2023129938A1Methods of treating neurological diseasesXINCOR INC·Filed 2022·Application pending·0 cites
- 1540US11365229B2Methods of treating neurological diseasesXENCOR INC·Filed 2013·Granted Jun 21, 2022·0 cites·8 claims
- 1639US2020172590A1Methods of treating neurological diseasesXENCOR INC·Filed 2019·Application pending·0 cites
- 1734US2010222272A1Pharmaceutical Compositions for the Treatment of TNF-Alpha Related DisordersXENCOR INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →